$OPK I was very optimistic about the upcoming earnings until I read the last cc and investor presentation transcripts. They pulled guidance, the other parts of their business is suffering because of Covid, and they don't really know the reimbursement rate for testing. Yes, earnings will be good but do some DD, they won't be great imo. The question is how much will the uptick in testing offset the loses sustained in the other parts of the business. Some people are saying the CEO said they were already profitable. Not true if you read the transcript. Nonetheless, I am buying some calls on Monday morning because I do see this going up some in the near future. Good luck.